Pfizer Withdraws Oxbryta, But Overall Market Impact May Be Limited

 
• By Alaric DeArment
  
European regulators recommended Oxbryta be suspended while a data review is ongoing. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet